Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2005
05/04/2005EP1411881B1 5ht2c receptor modulators
05/04/2005EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
05/04/2005EP1377164A4 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
05/04/2005EP1362048B1 Triazolo compounds as mmp inhibitors
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors
05/04/2005EP1259477B1 Aminoadamantane derivatives as therapeutic agents
05/04/2005EP1246790B1 Substituted 1 and 2 naphthol mannich bases
05/04/2005EP1242061B1 Use of bioactive metabolites of gepirone for the manufacture of a medicament for the treatment of psychological disorders
05/04/2005EP1221480B1 Polypeptide humanin inhibiting nerve cell death
05/04/2005EP1169029B1 Use of sibutramine or its derivative for the treatment of sleep disorders
05/04/2005EP1152762B1 Use of desoxypeganine in the treatment of alzheimer's dementia
05/04/2005EP1140830B1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
05/04/2005EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/04/2005EP1032368B1 Iontophoretic devices comprising piperidin derivatives
05/04/2005EP1023067B1 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
05/04/2005EP0966969B1 Anti-stress drugs and functional foods having anti-stress effects
05/04/2005EP0958280B1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/04/2005EP0672139B1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/04/2005CN1612941A Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene
05/04/2005CN1612877A Spiroazacyclic compounds as monoamine receptor modulators
05/04/2005CN1612876A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics
05/04/2005CN1612872A Process for the preparation of simvastatin
05/04/2005CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators
05/04/2005CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors
05/04/2005CN1612864A Novel alkansulfonamides as endothelin antagonists
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence
05/04/2005CN1612744A Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory
05/04/2005CN1612736A Imidazo (4, 3-e)-1, 2, 4-triazolo(1, 5-c) pyrimidines as adenosine A2A receptor antagonists
05/04/2005CN1612733A Benzimidazoles useful as protein kinase inhibitors
05/04/2005CN1612732A Analgesics and methods of use
05/04/2005CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
05/04/2005CN1612698A Modified methionine rich food products and process for their manufacture
05/04/2005CN1611509A Nucleic acid adaptor for specific identifying human cerebral acetylcholinesterase and its use
05/04/2005CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes
05/04/2005CN1611254A American ginseng fruit, and its medicinal composition and pharmaceutical use
05/04/2005CN1611245A Recovery liquid for skew mouth and eye
05/04/2005CN1611243A Gastrodia-pseudo-ginseng micro-powder composition
05/04/2005CN1611232A Medicinal composition with main effect of antifatigue, radioresistance and melancholia-resistance and its preparing method
05/04/2005CN1611213A Novel 13 uses of neoarsphenamine
05/04/2005CN1199974C Spiro (2H-1-benzopyran-2,4'-piperididine) derivates as glycine transport inhibitors
05/04/2005CN1199971C Quaternary ammonium compounds as tachykinin antagonists
05/04/2005CN1199969C New process
05/04/2005CN1199963C Coumarin derivatives with COMT inhibiting activity
05/04/2005CN1199960C Agarofuran derivativs, their preparing process, medicinal composition containing them and their medicinal usage
05/04/2005CN1199954C Benzodiazepine derivatives
05/04/2005CN1199950C Quinolene derivatives as anti-inflammation agents
05/04/2005CN1199946C Specific indole compound and its preparation and use in treating and preventing cancers
05/04/2005CN1199682C Active part of cold limbs powder and its prepn
05/04/2005CN1199675C Mother medicine
05/04/2005CN1199643C Use of timosaponin for preparing medicine for preventing and treating brain apoplexy
05/04/2005CN1199637C Use of GABA transport protein inhibitor in preparing medicine for treating alcohol habituation and abuse
05/04/2005CN1199623C Transdermal therapeutic system with nicotine and addition of monoterpene ketones
05/03/2005US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors
05/03/2005US6888001 Selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function.
05/03/2005US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines
05/03/2005US6887996 Compounds and their use
05/03/2005US6887987 DNA encoding the human serine protease T
05/03/2005US6887983 Purified 20 kDA presenilin 2 C-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
05/03/2005US6887905 Treatment of depression or generalized anxiety disorder
05/03/2005US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them
05/03/2005US6887884 For therapy of neurological and psychological disorders
05/03/2005US6887875 2,5-diarypyrimidine compounds
05/03/2005US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/03/2005US6887871 Use of phenylheteroakylamine derivatives
05/03/2005US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia
05/03/2005US6887868 Therapeutic 5-HT ligand compounds
05/03/2005US6887867 Psychological disorders
05/03/2005US6887865 N-heterocyclic derivatives as NOS inhibitors
05/03/2005US6887861 Drug delivery
05/03/2005US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM)
05/03/2005US6887676 For diagnosis/therapy/prevention of Creutzfeldt-Jacob disease
05/03/2005US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering
05/03/2005US6887476 Method for treating pain with botulinum toxin type B
05/03/2005US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata)
05/03/2005CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
05/03/2005CA2309558C Substituted oximes as neurokinin antagonists
05/03/2005CA2297486C 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
05/03/2005CA2157234C Stereoselective process for producing dihydro-2-3-benzodiazepine derivatives
05/03/2005CA2089767C Pyridinyl thiadiazolyl- and oxadiazolyl derivatives
04/2005
04/28/2005WO2005038027A1 Transgenic nonhuman mammal
04/28/2005WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof
04/28/2005WO2005037792A1 Derivatives of n-``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
04/28/2005WO2005037785A2 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
04/28/2005WO2005037783A2 Use of tricyclic compounds as glycine transport inhibitors
04/28/2005WO2005037782A2 Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
04/28/2005WO2005037781A2 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
04/28/2005WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate
04/28/2005WO2005007630A3 Aryl fused azapolycyclic compounds
04/28/2005WO2004108682A3 Tetrahydroisoquinolines as antagonists of the 5ht1b receptor
04/28/2005WO2004099213A3 Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists
04/28/2005WO2003099201A3 Compositions and methods of use for a fibroblast growth factor
04/28/2005WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
04/28/2005US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
04/28/2005US20050090555 Compound for the treatment of metabolic disorders
04/28/2005US20050090547 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
04/28/2005US20050090538 Potentiating an NSAID and/or acetaminophen analgesic by administering concurrently a cyclooxygenase-2 inhibitor such as celecoxib, meloxicam, nimesulide and/or rofecoxib
04/28/2005US20050090537 Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
04/28/2005US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease.
04/28/2005US20050090534 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy
1 ... 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 ... 1833